Dr. Michael Venincasa, MD

Dr. Venincasa practices at Cuero Regional Hospital in Cuero, Texas, part of DeWitt Medical District.

Dr. Venincasa's NPI, 1790728178, was assigned on June 14, 2006. Dr. Venincasa graduated from UT Southwestern Medical Center in 1986. Dr. Venincasa holds Texas license H3614.

Dr. Venincasa's primary practice is Cuero Regional Hospital, at 2550 N Esplanade, Cuero, TX 77954 in De Witt County. The practice phone is (361) 275-6191.

Dr. Venincasa's primary practice is Cuero Regional Hospital in Cuero, Texas, part of DeWitt Medical District. Dr. Venincasa is also affiliated with CHRISTUS Mother Frances Hospital - Jacksonville. The medical group on file is Access TeleCare. Dmand AI also links Dr. Venincasa to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Venincasa practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Venincasa's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Venincasa is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Venincasa's licenses on file in 15 states: Texas, New Mexico, California, Virginia, Arkansas, Arizona, Indiana, Louisiana, Minnesota, Missouri, Nevada, Oregon, Washington, North Carolina and Oklahoma.

Dmand AI lists atrial fibrillation and flutter, chronic hypertension, coronary artery disease, heart failure and heart valve disorders among the conditions Dr. Venincasa treats.

CMS data shows 200 Medicare services from Dr. Venincasa across 4 procedure codes in 2024, for 170 Medicare patients. Medicare paid $16,996 for them.

CMS counts 170 Medicare patients who saw Dr. Venincasa in 2024. The largest group is 75 to 84, with 60 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Venincasa's median patient age at 76, with 47% women.

In 2024, Dr. Venincasa wrote 30 Medicare Part D claims for 22 patients. 83% of them were for generic drugs. They cover 9 drugs, with $4,863 in total drug cost. In 2022, CMS named 63 claims across 2 drugs.

Dr. Venincasa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Venincasa as offering telehealth.

Dmand AI links 2 papers to Dr. Venincasa.

CMS Open Payments shows 355 general payments to Dr. Venincasa from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,250.

Dr. Venincasa graduated from UT Southwestern Medical Center in 1986. Dr. Venincasa is a member of ASNC.

Dr. Venincasa is in network with 24 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.